The NHS is launching the world's biggest trial of AI to detect breast cancer, screening two-thirds of 700,000 women. Five ...

Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light for NHS use. The Institute of Cancer Research, London, (ICR) – which worked on ...

Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.

Health chiefs have announced the biggest rollout of artificial intelligence in the NHS in an attempt to speed up breast ...

Prostate cancer has become England's most common cancer as more men are getting checked. Prostate Cancer UK analysis shows diagnoses of the disease overtook breast cancer in 2022 and 2023.

Analysis of NHS data by Prostate Cancer UK found 50,751 men were diagnosed with prostate cancer in England in 2022 compared with 48,531 diagnoses of breast cancer. The figures increased again in ...

there were 50,751 men diagnosed with prostate cancer in England, surpassing the 48,531 breast cancer diagnoses, according to NHS data. This trend became even more pronounced just a year later when ...